Last reviewed · How we verify
NCT06699095: HoReConCareMS
Home Rehabilitation As Continuity of Care in MS
NA trial testing Telerehabilitation in Multiple Sclerosis in 20 participants. Currently enrolling.
6 November 2025
Quick facts
| Lead sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 20 |
| Start date | 6 November 2024 |
| Primary completion | 6 November 2025 |
| Estimated completion | 15 November 2025 |
| Sites | 3 locations across Italy |
Drugs / interventions tested
- Telerehabilitation
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta — full company profile →
Who can join
Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06699095
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Telerehabilitation
Trials testing the same drug.
- NCT07327008 — The Effectiveness of Telerehabilitation in Liver Transplant Patients · NA · not yet recruiting
- NCT07310914 — Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis · Phase 2 · not yet recruiting
- NCT07302386 — Exercise Management in Parkinson's Disease · NA · recruiting
- NCT06984380 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP) · NA · not yet recruiting
- NCT06871072 — Telerehabilitation for Multiple Sclerosis · NA · completed
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta trials
Trials by the same sponsor.
- NCT07168850 — Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia · NA · recruiting
- NCT06933212 — Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy. · recruiting
- NCT06584097 — COMparative Performance of General Purpose Models · recruiting
- NCT07427940 — Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments · NA · recruiting
- NCT06844838 — FASt Track in Elective Neurosurgery: the Role of Low Propofol Bis-NOL Guided General Anaesthesia for Full, Early and Saf · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06699095 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Last refreshed: 21 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06699095.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing